167 related articles for article (PubMed ID: 29467012)
1. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
[TBL] [Abstract][Full Text] [Related]
2. Clinically Relevant Imaging Features for
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1439-1445. PubMed ID: 30002055
[TBL] [Abstract][Full Text] [Related]
3. Radiomics for predicting MGMT status in cerebral glioblastoma: comparison of different MRI sequences.
Zheng F; Zhang L; Chen H; Zang Y; Chen X; Li Y
J Radiat Res; 2024 May; 65(3):350-359. PubMed ID: 38650477
[TBL] [Abstract][Full Text] [Related]
4. Development of A Radiomic Model for
Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308
[TBL] [Abstract][Full Text] [Related]
5.
Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W
Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864
[TBL] [Abstract][Full Text] [Related]
6. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
Han L; Kamdar MR
Pac Symp Biocomput; 2018; 23():331-342. PubMed ID: 29218894
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Three Different Deep Learning-Based Models to Predict the MGMT Promoter Methylation Status in Glioblastoma Using Brain MRI.
Faghani S; Khosravi B; Moassefi M; Conte GM; Erickson BJ
J Digit Imaging; 2023 Jun; 36(3):837-846. PubMed ID: 36604366
[TBL] [Abstract][Full Text] [Related]
8. MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models.
Saeed N; Ridzuan M; Alasmawi H; Sobirov I; Yaqub M
Med Image Anal; 2023 Dec; 90():102989. PubMed ID: 37827111
[TBL] [Abstract][Full Text] [Related]
9. Predominance of MGMT promoter methylation among Pakistani glioblastoma patients.
Muhammad N; Fasih S; Malik B; Hameed S; Loya A; Rashid MU
Mol Biol Rep; 2024 Mar; 51(1):433. PubMed ID: 38520591
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.
Xing Z; Huang W; Su Y; Yang X; Zhou X; Cao D
Clin Radiol; 2022 Aug; 77(8):e576-e584. PubMed ID: 35469666
[TBL] [Abstract][Full Text] [Related]
11. A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature.
Zinn PO; Sathyan P; Mahajan B; Bruyere J; Hegi M; Majumder S; Colen RR
PLoS One; 2012; 7(8):e41522. PubMed ID: 22870228
[TBL] [Abstract][Full Text] [Related]
12. Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing.
Halldorsson S; Nagymihaly RM; Patel A; Brandal P; Panagopoulos I; Leske H; Lund-Iversen M; Sahm F; Vik-Mo EO
Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12984. PubMed ID: 38783575
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.
Oliver JA; Ortiz R; Melguizo C; Alvarez PJ; Gómez-Millán J; Prados J
BMC Cancer; 2014 Jul; 14():511. PubMed ID: 25015560
[TBL] [Abstract][Full Text] [Related]
15. Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.
Zhong S; Ren JX; Yu ZP; Peng YD; Yu CW; Deng D; Xie Y; He ZQ; Duan H; Wu B; Li H; Yang WZ; Bai Y; Sai K; Chen YS; Guo CC; Li DP; Cheng Y; Zhang XH; Mou YG
J Neurosurg; 2023 Aug; 139(2):305-314. PubMed ID: 36461822
[TBL] [Abstract][Full Text] [Related]
16. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.
Korfiatis P; Kline TL; Lachance DH; Parney IF; Buckner JC; Erickson BJ
J Digit Imaging; 2017 Oct; 30(5):622-628. PubMed ID: 28785873
[TBL] [Abstract][Full Text] [Related]
17. MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma.
Tasci E; Shah Y; Jagasia S; Zhuge Y; Shephard J; Johnson MO; Elemento O; Joyce T; Chappidi S; Cooley Zgela T; Sproull M; Mackey M; Camphausen K; Krauze AV
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612892
[TBL] [Abstract][Full Text] [Related]
18. Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide.
Flies CM; Friedrich M; Lohmann P; van Garderen KA; Smits M; Tonn JC; Weller M; Galldiks N; Snijders TJ
Neuro Oncol; 2024 May; 26(5):902-910. PubMed ID: 38219019
[TBL] [Abstract][Full Text] [Related]
19. Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Zhang Y; Zhu J
Oncol Rep; 2019 Feb; 41(2):908-916. PubMed ID: 30535433
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.
Rosas-Alonso R; Colmenarejo-Fernández J; Pernía O; Burdiel M; Rodríguez-Antolín C; Losantos-García I; Rubio T; Moreno-Velasco R; Esteban-Rodríguez I; Martínez-Marín V; Yubero P; Costa-Fraga N; Díaz-Lagares A; López-López R; Díaz-Martin E; García JF; Sánchez CV; Gandía-González ML; Moreno-Bueno G; de Castro J; de Cáceres II
Sci Rep; 2024 May; 14(1):11398. PubMed ID: 38762534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
